Business Description
Medico Remedies Ltd
ISIN : INE630Y01024
Share Class Description:
NSE:MEDICO: Ordinary SharesCompare
Compare
Traded in other countries / regions
MEDICO.India IPO Date
2022-05-26Description
Medico Remedies Ltd is a manufacturer, supplier, and exporter of pharmaceutical drugs. It focuses on the production and marketing of anti-infective, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics, and other supplements. In addition, it also sells other drugs such as antihistaminic, antidiabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.07 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | 0.63 | |||||
| Interest Coverage | 14.07 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 6.27 | |||||
| Beneish M-Score | -2.41 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16 | |||||
| 3-Year EBITDA Growth Rate | 41.7 | |||||
| 3-Year EPS without NRI Growth Rate | 64.3 | |||||
| 3-Year Book Growth Rate | 13.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 48.91 | |||||
| 9-Day RSI | 36.82 | |||||
| 14-Day RSI | 30.88 | |||||
| 6-1 Month Momentum % | -33.81 | |||||
| 12-1 Month Momentum % | -40.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.52 | |||||
| Quick Ratio | 1.22 | |||||
| Cash Ratio | 0.16 | |||||
| Days Inventory | 65.07 | |||||
| Days Sales Outstanding | 126.61 | |||||
| Days Payable | 126.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 1.09 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.95 | |||||
| Operating Margin % | 6.68 | |||||
| Net Margin % | 5.37 | |||||
| FCF Margin % | 1.21 | |||||
| ROE % | 15.91 | |||||
| ROA % | 7.3 | |||||
| ROIC % | 12.17 | |||||
| ROC (Joel Greenblatt) % | 20.99 | |||||
| ROCE % | 21.72 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 54.59 | |||||
| PE Ratio without NRI | 54.59 | |||||
| Shiller PE Ratio | 146.19 | |||||
| Price-to-Owner-Earnings | 82.6 | |||||
| PEG Ratio | 2.31 | |||||
| PS Ratio | 2.92 | |||||
| PB Ratio | 7.89 | |||||
| Price-to-Tangible-Book | 8.13 | |||||
| Price-to-Free-Cash-Flow | 238.47 | |||||
| Price-to-Operating-Cash-Flow | 46.05 | |||||
| EV-to-EBIT | 38.94 | |||||
| EV-to-EBITDA | 30.24 | |||||
| EV-to-Revenue | 3 | |||||
| EV-to-FCF | 252.11 | |||||
| Price-to-DCF (Earnings Based) | 2.36 | |||||
| Price-to-DCF (FCF Based) | 26.56 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.27 | |||||
| Price-to-Graham-Number | 4.25 | |||||
| Price-to-Net-Current-Asset-Value | 14.89 | |||||
| Earnings Yield (Greenblatt) % | 2.56 | |||||
| FCF Yield % | 0.41 | |||||
| Forward Rate of Return (Yacktman) % | 19.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medico Remedies Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,296.5 | ||
| EPS (TTM) (₹) | 0.83 | ||
| Beta | 0 | ||
| Volatility % | 53.14 | ||
| 14-Day RSI | 30.88 | ||
| 14-Day ATR (₹) | 3.012453 | ||
| 20-Day SMA (₹) | 47.8975 | ||
| 12-1 Month Momentum % | -40.26 | ||
| 52-Week Range (₹) | 44.5 - 100.7 | ||
| Shares Outstanding (Mil) | 82.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medico Remedies Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medico Remedies Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medico Remedies Ltd Frequently Asked Questions
What is Medico Remedies Ltd(NSE:MEDICO)'s stock price today?
The current price of NSE:MEDICO is ₹46.75. The 52 week high of NSE:MEDICO is ₹100.70 and 52 week low is ₹44.50.
When is next earnings date of Medico Remedies Ltd(NSE:MEDICO)?
The next earnings date of Medico Remedies Ltd(NSE:MEDICO) is .
Does Medico Remedies Ltd(NSE:MEDICO) pay dividends? If so, how much?
Medico Remedies Ltd(NSE:MEDICO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers